3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
15
Ovarian Neoplasms
3
Colorectal Neoplasms
3
Neoplasms, Unknown Primary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Carcinoma, Intraductal, Noninfiltrating
2
Brain Neoplasms
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Urogenital Neoplasms
1
Primary Ovarian Insufficiency
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Hot Flashes
1
Hormone Receptor Positive Breast Cancer
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Digestive System Neoplasms
1
Depression
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Central Nervous System Neoplasms
1
Cardiovascular Diseases
1
Breast Screening
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
abemaciclib
1
Trastuzumab
1
Tablets
1
Genetic Testing
1
Fulvestrant
1
Everolimus
1
Blood Specimen Collection
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hormone Receptor Positive Breast Cancer
×
Genetic Testing
×
Breast
×
Clear all
NCT07646171
2026-06-12
MBC
Tel-Aviv Sourasky Medical Center
Recruiting
19 enrolled